Press release -

Halo Genomics expands its European distributor network

Halo Genomics’ distribution network grew today as Halo Genomics signed a distribution agreement with Ozyme. The agreement between the companies allows Ozyme to distribute the Selector and HaloPlex™ PCR product lines in France.

Founded in 1984, Ozyme specializes in cell and molecular biology products for research applications. The company is headquartered in Paris and provides full sales and technical support service.

Maria Hjortsmark, CBO of Halo Genomics says:” The interest in our product lines continues to grow and highly skilled local partners such as Ozyme will further strengthen our ability to support our customers.”

“This agreement clearly shows Ozyme’s commitment to offer a broader selection of products to the next generation sequencing market.” said Martin Lauriot Prevost, President of Ozyme.

Learn more about Ozyme at http://www.ozyme.fr.

Halo Genomics is exhibiting at the European Human Genetics Conference in Amsterdam this weekend, https://www.eshg.org/260.0.html.

Related links

Topics

  • Science, technology

Categories

  • targeted resequencing
  • target enrichment
  • sample enrichment
  • resequencing
  • next generation sequencing (ngs).

Halo Genomics is a provider of innovative technology for sample preparation in next generation sequencing. Halo Genomics was founded by scientists from Uppsala University and Olink AB. Based in Uppsala, Sweden, the company's solutions are offered to a wide range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the world.

Contacts

Olle Ericsson

Press contact CEO, Co-founder +46 18 495 31 20

Related content